Company / Capital Expenditures
CHINA PHARMA HOLDINGS, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$59.3K
FY2025
5-year range
$11.5K / $867.3K
FY2021-FY2025
Trend
+415.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures changed +415% YoY in FY2025, a notable deviation from the 9-year average annual change of +112%.
Based on SEC 10-K filings.
$59,324 in FY2025 with a 5-year CAGR of -15.3%.
Improved from $11,517 to $59,324 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -47.2%
- 5-Year CAGR
- -15.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.3%, indicating a declining trend.
- In FY2025, capital expenditures increased 415.1% year-over-year.
- Peak capital expenditures was recorded in FY2021.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.3K | +415.1% |
| FY2024 | $11.5K | +0.0% |
| FY2023 | $11.5K | -97.1% |
| FY2022 | $402.0K | -53.7% |
| FY2021 | $867.3K | +537.7% |
| FY2020 | $136.0K | +165.9% |
| FY2019 | $51.1K | -62.5% |
| FY2018 | $136.5K | -29.4% |
| FY2017 | $193.4K | +128.2% |
| FY2016 | -$685.3K | -113.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026